| 1 |
26655108 | Comparison of enzyme kinetics of warfarin analyzed by LC-MS/MS QTrap and differential mobility spectrometry. | 2016 Jan 1 |
1 |
| 2 |
24174816 | Inhibitory effect of mitragynine on human cytochrome P450 enzyme activities. | 2013 Oct |
1 |
| 3 |
22022918 | Ilaprazole, a new proton pump inhibitor, is primarily metabolized to ilaprazole sulfone by CYP3A4 and 3A5. | 2012 Mar |
1 |
| 4 |
21277363 | Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes. | 2011 Apr 10 |
1 |
| 5 |
21550074 | Ritonavir inhibits the two main prasugrel bioactivation pathways in vitro: a potential drug-drug interaction in HIV patients. | 2011 Nov |
1 |
| 6 |
18950609 | Metabolism Comparative Cytotoxicity Assay (MCCA) and Cytotoxic Metabolic Pathway Identification Assay (CMPIA) with cryopreserved human hepatocytes for the evaluation of metabolism-based cytotoxicity in vitro: proof-of-concept study with aflatoxin B1. | 2009 Apr 15 |
1 |
| 7 |
16556082 | Drug interactions during therapy with three major groups of antimicrobial agents. | 2006 Apr |
1 |
| 8 |
14709627 | Highly selective inhibition of human CYP3Aa in vitro by azamulin and evidence that inhibition is irreversible. | 2004 Jan |
1 |
| 9 |
15304426 | The involvement of CYP3A4 and CYP2C9 in the metabolism of 17 alpha-ethinylestradiol. | 2004 Nov |
1 |
| 10 |
15373932 | Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects. | 2004 Oct |
1 |
| 11 |
11854151 | Inhibition of cytochromes P450 by antifungal imidazole derivatives. | 2002 Mar |
1 |
| 12 |
9925971 | In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes. | 1999 Mar |
1 |
| 13 |
10078840 | Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential. | 1999 Jan |
1 |
| 14 |
10418968 | Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. | 1999 Jun 1 |
1 |
| 15 |
9531525 | Overlapping substrate specificities of cytochrome P450 3A and P-glycoprotein for a novel cysteine protease inhibitor. | 1998 Apr |
1 |
| 16 |
9037249 | Variable contribution of cytochromes P450 2D6, 2C9 and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes. | 1997 Jan 24 |
1 |
| 17 |
9353355 | Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples. | 1997 Nov |
1 |